Analytical Data
-
Gene name
CWF19L1
- Application
-
Alternative Names
CWF19L1CWF19-like protein 1; C19L1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q69YN2
-
Expression Region
1-538aa
-
AA Sequence
MAQKPLRLLACGDVEGKFDILFNRVQAIQKKSGNFDLLLCVGNFFGSTQDAEWEEYKTGIKKVPIQTYVLGANNQETVKYFQDADGCELAENITYLGRKGIFTGSSGLQIVYLSGTESLNEPVPGYSFSPKDVSSLRMMLCTTSQFKGVDILLTSPWPKCVGNFGNSSGEVDTKKCGSALVSSLATGLKPRYHFAALEKTYYERLPYRNHIILQENAQHATRFIALANVGNPEKKKYLYAFSIVPMKLMDAAELVKQPPDVTENPYRKSGQEASIGKQILAPVEESACQFFFDLNEKQGRKRSSTGRDSKSSPHPKQPRKPPQPPGPCWFCLASPEVEKHLVVNIGTHCYLALAKGGLSDDHVLILPIGHYQSVVELSAEVVEEVEKYKATLRRFFKSRGKWCVVFERNYKSHHLQLQVIPVPISCSTTDDIKDAFITQAQEQQIELLEIPEHSDIKQIAQPGAAYFYVELDTGEKLFHRIKKNFPLQFGREVLASEAILNVPDKSDWRQCQISKEDEETLARRFRKDFEPYDFTLDD
-
Molecular Weight
87 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CWF19L1, a member of the CWF family of proteins, plays a crucial role in the regulation of cell cycle progression and RNA processing. Research on CWF19L1 has gained traction due to its potential implications in various biological processes, including cellular development, DNA repair, and gene expression regulation. Alterations in the function or expression of CWF19L1 have been implicated in several diseases, particularly in cancer, where abnormal cell proliferation is a hallmark. The study of CWF19L1 recombinant proteins aims to elucidate its functional mechanisms and interactions within the cellular environment. By producing and characterizing CWF19L1 recombinant proteins, researchers can explore its structural properties and binding capabilities, which are essential for understanding its role in chromatin remodeling and spliceosome assembly. Furthermore, investigating CWF19L1's interaction partners may provide insights into its involvement in oncogenic processes and highlight its potential as a therapeutic target. Thus, the study of CWF19L1 recombinant proteins represents a significant avenue for advancing our knowledge of cellular regulation and developing novel strategies for cancer treatment.











